Revista de gastroenterologia de Mexico (English)最新文献_第8页

Comparative analysis of patients transplanted due to hepatocellular carcinoma. Are there survival differences between those who meet the Milan criteria and those who exceed them? 肝癌肝细胞移植患者的比较分析。那些达到米兰标准的人和那些超过米兰标准的人之间存在生存差异吗？

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-01-01 DOI: 10.1016/j.rgmxen.2024.06.007

M.H. Mohamed-Chairi , A.B. Vico-Arias , N. Zambudio-Carroll , M.T. Villegas-Herrera , J.M. Villar-del-Moral

{"title":"Comparative analysis of patients transplanted due to hepatocellular carcinoma. Are there survival differences between those who meet the Milan criteria and those who exceed them?","authors":"M.H. Mohamed-Chairi , A.B. Vico-Arias , N. Zambudio-Carroll , M.T. Villegas-Herrera , J.M. Villar-del-Moral","doi":"10.1016/j.rgmxen.2024.06.007","DOIUrl":"10.1016/j.rgmxen.2024.06.007","url":null,"abstract":"<div><h3>Introduction and aim</h3><div>The Milan criteria have been the subject of discussion in recent years due to their restrictive nature. Expansion of the criteria and the use of locoregional therapies to downstage patients and increase the number of transplant candidates have been proposed. Our study analyzed the results of patients that underwent transplant due to hepatocellular carcinoma, comparing those that met the Milan criteria and those that exceeded them.</div></div><div><h3>Materials and methods</h3><div>A retrospective, observational, single-center study was conducted on liver transplantations due to hepatocellular carcinoma, within the time frame of 2010−2021. Demographic and clinical variables, overall survival, and disease-free survival were analyzed. The Student’s t test or Mann–Whitney U test were applied for the quantitative variables and the Fisher’s exact test for the categorical variables. The survival function was estimated through the Kaplan–Meier method and the log-rank test was applied for comparing the groups.</div></div><div><h3>Results</h3><div>Of the 96 transplanted patients, 78 met the Milan criteria and 18 exceeded them. Patients that did not meet the Milan criteria had a higher number of nodules (1.6 vs. 3.5 nodules; p = 0.000), larger main lesions (24.38 vs. 38.55 mm; p = 0.000), a higher bilobar hepatocellular carcinoma rate (21.79% vs. 72.22%, p = 0.000), and higher tumor burden. There were no significant differences regarding overall survival, but there was a lower rate of disease-free survival in the group exceeding the criteria.</div></div><div><h3>Conclusion</h3><div>Downstaged patients that received locoregional therapies had lower disease-free survival rates than patients that met the Milan criteria, but there were no significant differences regarding overall survival.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 36-43"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Commentary on the article “Prevalence and characteristics of gastroesophageal reflux disease in pregnant women” 《孕妇胃食管反流病的患病率及特点》一文评论

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-01-01 DOI: 10.1016/j.rgmxen.2024.07.006

M. Gómez, G. Jara

引用次数: 0

Elevated fecal calprotectin: Does capsule endoscopy have a role in the diagnostic algorithm? 粪钙保护蛋白升高：胶囊内窥镜在诊断算法中有作用吗？

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-01-01 DOI: 10.1016/j.rgmxen.2024.06.006

S. Vibhishanan , P. Oka , S. Zammit , R. Sidhu

{"title":"Elevated fecal calprotectin: Does capsule endoscopy have a role in the diagnostic algorithm?","authors":"S. Vibhishanan , P. Oka , S. Zammit , R. Sidhu","doi":"10.1016/j.rgmxen.2024.06.006","DOIUrl":"10.1016/j.rgmxen.2024.06.006","url":null,"abstract":"<div><h3>Introduction</h3><div>The purpose of this study was to examine the utility of small bowel capsule endoscopy (SBCE) in the diagnostic pathway of patients that had elevated fecal calprotectin (FC) and normal colonoscopy.</div></div><div><h3>Methods</h3><div>Patients with elevated FC and normal colonoscopy that underwent SBCE in the last 4 years were included. Patients were divided into 3 groups: group 1: patients with isolated small bowel Crohn’s disease (SBCD) on SBCE; group 2: patients with elevated FC but normal SBCE; and group 3: patients with isolated terminal ileitis.</div></div><div><h3>Results</h3><div>The study included 320 patients (group 1: 254 patients, group 2: 50 patients, and group 3: 16 patients). The median age was 42.5 years (IQR 26) across the three groups and 52.4% of the patients had a new diagnosis of SBCD. In group 1, active disease was identified distally in 247 patients (77.2%), proximal involvement in 90 patients (28.1%), and extensive SBCD in 68 patients (21.3%). Magnetic resonance enterography (MRE) was carried out in 229 (90.1%) patients in group 1 and was negative in 42 patients with SBCD. The diagnostic yield of SBCE was higher than that of MRE (p < 0.0001). In group 2, the final diagnoses included <em>Helicobacter pylori</em> infection (n = 2), NSAID use (n = 3), celiac disease (n = 2), and microscopic colitis (n = 1). The final diagnoses in group 3 were idiopathic terminal ileitis (n = 11), inflammatory bowel disease (n = 3), and infective terminal ileitis (n = 2).</div></div><div><h3>Conclusion</h3><div>SBCE influences the patient pathway even when negative/normal. It is better at identifying early SBCD, when compared with MRE.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 29-35"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Response to Gómez-Calero et al. concerning their comments on the article “Prevalence and characteristics of gastroesophageal reflux disease in pregnant women” 对Gómez-Calero等人对《孕妇胃食管反流病的患病率和特点》一文中评论的回应

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-01-01 DOI: 10.1016/j.rgmxen.2024.09.008

M.N. Luu , D.T. Quach

引用次数: 0

Acute small bowel obstruction caused by a hemobezoar in a peptic ulcer case 消化性溃疡病例中由血黄引起的急性小肠阻塞

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-01-01 DOI: 10.1016/j.rgmxen.2024.09.006

E.A. Montemayor-Garza , L. Santoyo-Fexas , M.I. Wah-Suárez , L.A. González-Torres , R.A. López-Pérez , S. Ramírez-Peña

引用次数: 0

Gastrointestinal bleeding in an adult patient with Turner syndrome secondary to vascular malformations 成人特纳综合征继发于血管畸形的消化道出血1例

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-01-01 DOI: 10.1016/j.rgmxen.2024.08.005

F.P. Carvajal-González , P.Y. Gil-Galleguillos , L.C. Gil-La Rota , P.A. Muñoz-Dimitrov , P.F. Toledo-Arancibia

引用次数: 0

The role of conservative treatment in esophageal perforation caused by the ingestion of a blister pack: A case report and literature review 保守治疗在误食水疱包引起的食管穿孔中的作用：1例报告及文献复习。

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-01-01 DOI: 10.1016/j.rgmxen.2024.11.001

J.P. Pérez-Macías , M.E. Ramírez-Solís , A.Y. Ortega-Caballero , A.I. Hernández-Guerrero , E.F. Marquez-Bornio

引用次数: 0

Noncardiac chest pain beyond the esophagus: Hiatal hernia type III (mixed) 食管外非心源性胸痛：III型裂孔疝（混合型）

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-01-01 DOI: 10.1016/j.rgmxen.2024.07.005

C.A. Bautista-Mondragón , J.E. Aquino-Matus , M. Figueroa-Palafox , C. Culebro-García , L.R. Valdovinos-García

引用次数: 0

Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study 智利肠易激综合征患者小肠细菌过度生长的治疗：一项前瞻性和比较研究

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-01-01 DOI: 10.1016/j.rgmxen.2024.08.003

C. von Muhlenbrock , G. Landskron , A.M. Madrid

{"title":"Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study","authors":"C. von Muhlenbrock , G. Landskron , A.M. Madrid","doi":"10.1016/j.rgmxen.2024.08.003","DOIUrl":"10.1016/j.rgmxen.2024.08.003","url":null,"abstract":"<div><h3>Introduction and aim</h3><div>Patients with disorders of the gut-brain axis, such as irritable bowel syndrome (IBS), often exhibit small intestinal bacterial overgrowth (SIBO). Its treatment includes rifaximin (RF), ciprofloxacin (CF), neomycin, sulfamethoxazole-trimethoprim, and metronidazole (MZ). RF is a non-absorbable antibiotic, postulated to have fewer adverse effects. Our aim was to assess symptomatic response and SIBO eradication in patients with IBS, using three antibiotic regimens.</div></div><div><h3>Methods</h3><div>A prospective, randomized, double-blind study was conducted on IBS patients over 18 years of age, utilizing the Rome IV questionnaire and lactulose breath test. Those diagnosed with SIBO were randomly assigned to receive antibiotic treatment. Group A was treated with RF, group B with CF, and group C with MZ, each for 10 days. Treatment response was evaluated based on the SIBO eradication rate 15 days after completing therapy, utilizing hydrogen and methane breath tests with lactulose. Self-reported symptoms were recorded on a 10-point Likert scale before, during, and after treatment.</div></div><div><h3>Results</h3><div>Ninety-seven patients with IBS and SIBO were included, 81% of whom completed treatment. Fifty-nine percent of the patients treated with RF achieved SIBO eradication, compared with 53% and 79% of those treated with CR and MZ, respectively. Metronidazole reduced more methane levels, compared with the other groups. However, the greatest reduction in abdominal pain and bloating was observed in the RF group, with a lower percentage of adverse events.</div></div><div><h3>Conclusions</h3><div>Patients with IBS and SIBO benefit from antibiotic therapy. MZ exhibited the best SIBO eradication rate, but RF demonstrated greater symptomatic improvement and a lower rate of adverse effects.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 54-62"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143912308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Transitioning from NAFLD to MAFLD to MASLD in the Mexican population 墨西哥人口从NAFLD到MAFLD再到MASLD的转变

Revista de gastroenterologia de Mexico (English) Pub Date : 2025-01-01 DOI: 10.1016/j.rgmxen.2024.09.007

B.A. Priego-Parra , R. Bernal-Reyes , M.E. Icaza-Chávez , S.E. Martínez-Vázquez , J.M. Remes-Troche

引用次数: 0